Human immune response to monoclonal antibodies
- PMID: 8110730
- DOI: 10.1097/00002371-199401000-00006
Human immune response to monoclonal antibodies
Abstract
Monoclonal antibodies either of mouse, mouse/human chimeric, or human origin have been used safely in human trials for a decade. Considerable effort has been committed in investigations of manipulating endogenous immunological activity against tumors and targeting various cytotoxic agents to cancers. These studies have identified several problems that need to be resolved before any such reagents can be used routinely in patients. One of these problems has been the immunogenicity of these monoclonal antibodies. This review article discusses what is known regarding human immune response to monoclonal antibodies and their clinical consequences.
Similar articles
-
Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.Anticancer Res. 1996 Mar-Apr;16(2):661-74. Anticancer Res. 1996. PMID: 8687112 Review.
-
Analysis of HLA specificity of human monoclonal antibodies by cytofluorimetry and cell ELISA.Eur J Immunogenet. 1991 Oct-Dec;18(5-6):345-53. doi: 10.1111/j.1744-313x.1991.tb00034.x. Eur J Immunogenet. 1991. PMID: 1772879
-
Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.Curr Pharm Des. 2000 Feb;6(3):261-76. doi: 10.2174/1381612003401109. Curr Pharm Des. 2000. PMID: 10637379 Review.
-
[Monoclonal antibodies against determinants on human MHC class II antigens].Allerg Immunol (Leipz). 1990;36(4):309-20. Allerg Immunol (Leipz). 1990. PMID: 1711285 German.
-
[Antibody treatment for cancer].Nihon Geka Gakkai Zasshi. 2000 Sep;101(9):607-11. Nihon Geka Gakkai Zasshi. 2000. PMID: 11022675 Review. Japanese.
Cited by
-
In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery properties.Front Microbiol. 2022 Sep 26;13:962124. doi: 10.3389/fmicb.2022.962124. eCollection 2022. Front Microbiol. 2022. PMID: 36225354 Free PMC article. Review.
-
Near-infrared photoimmunotherapy targeting GPR87: Development of a humanised anti-GPR87 mAb and therapeutic efficacy on a lung cancer mouse model.EBioMedicine. 2021 May;67:103372. doi: 10.1016/j.ebiom.2021.103372. Epub 2021 May 13. EBioMedicine. 2021. PMID: 33993055 Free PMC article.
-
The full-length recombinant human antibody to vaccinia virus.Dokl Biochem Biophys. 2006 Mar-Apr;407:98-101. doi: 10.1134/s1607672906020141. Dokl Biochem Biophys. 2006. PMID: 16776076 No abstract available.
-
Modulation of the CD40-CD40 ligand interaction using human anti-CD40 single-chain antibody fragments obtained from the n-CoDeR phage display library.Immunology. 2002 Aug;106(4):456-63. doi: 10.1046/j.1365-2567.2002.01473.x. Immunology. 2002. PMID: 12153507 Free PMC article.
-
Guided selection of an anti-gamma-seminoprotein human Fab for antibody directed enzyme prodrug therapy of prostate cancer.Cancer Immunol Immunother. 2007 Apr;56(4):477-89. doi: 10.1007/s00262-006-0202-2. Epub 2006 Jul 26. Cancer Immunol Immunother. 2007. PMID: 16868778 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources